JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1989; 13:434-441
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicklas, J.
Right arrow Articles by Pitt, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicklas, J.
Right arrow Articles by Pitt, B

Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina

JM Nicklas, EJ Topol, N Kander, WW O'Neill, JA Walton, SG Ellis, L Gorman, and B Pitt

Department of Internal Medicine, University of Michigan, Ann Arbor.

Angiographic, angioscopic and pathologic reports have recently demonstrated a high incidence of intracoronary thrombus in patients with unstable angina. To determine if thrombolysis could be beneficial when combined with maximal medical therapy, 40 patients with rest angina, angiographically documented coronary artery disease and pacing-induced ischemia were randomly assigned to intravenous recombinant tissue-type plasminogen activator (rt-PA, 150 mg/8 h) or placebo in a prospective double-blind trial. All patients received nitrates, a beta-adrenergic blocking agent, a calcium channel blocker, aspirin and heparin. Pacing thresholds for ischemia and quantitative coronary stenosis were measured before and after infusion of the study medication. Intracoronary thrombus was identified angiographically before infusion of the study medication in 16 patients; 7 received rt-PA and 9 received placebo. The ischemic pacing threshold in patients treated with rt-PA increased from 112 +/- 4 beats/min at baseline to 127 +/- 5 beats/min (p = 0.007) by the end of the infusion versus an insignificant change in patients who received placebo (from 116 +/- 4 to 119 +/- 4 beats/min, p = NS). In patients with intracoronary thrombus, the ischemic pacing threshold increased 26 +/- 7 beats/min with rt-PA treatment versus 0 +/- 3 beats/min with placebo (p = 0.004). In contrast, in patients without thrombus, there was no difference in ischemic pacing threshold increments between treatment groups (7 +/- 11 beats/min for rt-PA versus 6 +/- 5 beats/min for placebo, p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
G. N. Levine, M. N. Ali, and A. I. Schafer
Antithrombotic Therapy in Patients With Acute Coronary Syndromes
Arch Intern Med, April 9, 2001; 161(7): 937 - 948.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. A. McCullough, W. W. O'Neill, M. Graham, R. J. Stomel, F. Rogers, S. David, A. Farhat, R. Kazlauskaite, M. Al-Zagoum, and C. L. Grines
A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 596 - 605.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
TPA FOR UNSTABLE ANGINA?
Journal Watch (General), February 24, 1989; 1989(224): 3 - 3.
[Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.